Formyl-HIST1H4A (K59) Antibody

Shipped with Ice Packs
In Stock

Description

Histone Modifications and Antibody Development

Histone post-translational modifications (PTMs), such as formylation, acetylation, methylation, and phosphorylation, regulate chromatin accessibility and gene expression. Formylation is a less-studied PTM compared to acetylation or methylation but has emerged as a critical marker in cellular processes, including DNA repair and transcriptional regulation .

Antibodies targeting histone PTMs are validated through techniques such as:

  • Western Blot (WB): Detects modified histones in cell lysates.

  • Chromatin Immunoprecipitation (ChIP): Identifies genomic regions enriched with specific modifications.

  • Immunofluorescence (IF): Visualizes subcellular localization .

For example, antibodies against acetylated or methylated histones (e.g., H3K27me3) are rigorously validated for specificity, often requiring synthetic peptides or knockout models .

Formyl-HIST1H4A (K59) Antibody: Definition and Significance

Formyl-HIST1H4A (K59) Antibody targets histone H4 formylated at lysine 59. This modification may influence chromatin dynamics, though its exact biological role remains understudied. Key characteristics include:

FeatureDetails
TargetHistone H4 (HIST1H4A), lysine 59 (K59) formylated
ModificationFormylation (addition of a formyl group to lysine)
ApplicationsWestern Blot, ELISA, ChIP (hypothetical, based on similar antibodies)
Host/IsotypeLikely rabbit polyclonal (inferred from related antibodies)
ReactivityHuman (if aligned with Anti-Mono-methyl-HIST1H4A (K59) Antibody)

While no direct studies on this antibody exist, its development aligns with methodologies used for other formyl-specific antibodies (e.g., Formyl-HIST1H2AG (K95) or Formyl-HIST1H1C (K109)) .

Research Applications and Methods

Formyl-HIST1H4A (K59) Antibody would likely be employed in studies exploring:

  • Chromatin State and Gene Regulation: Investigating how K59 formylation impacts transcriptional activation or repression.

  • DNA Damage Response: Linking K59 formylation to repair mechanisms, as seen with other histone PTMs .

Comparison of Formyl-Specific Antibodies

AntibodyTargetApplicationsSource
Formyl-HIST1H2AG (K95)H2AK95 formylationICC, IF
Formyl-HIST1H1C (K109)H1CK109 formylationWB, ICC, IF
Formyl-HIST1H3A (K18)H3K18 formylationIF
Formyl-HIST1H4A (K59)H4K59 formylationWB, ELISA, ChIPHypothetical

Note: The Formyl-HIST1H4A (K59) Antibody is not listed in available catalogs, but its potential applications are inferred from related reagents.

Key Challenges

  1. Specificity Validation: Antibodies must distinguish formylation from structurally similar modifications (e.g., acetylation) .

  2. Limited Precedent: Few studies address H4K59 formylation, complicating validation and interpretation .

  3. Commercial Availability: No confirmed suppliers exist for this antibody, though companies like CUSABIO and Assay Genie offer formyl-specific antibodies for other histones .

Supporting Evidence from Related Antibodies

  • Antigen Preparation: Synthetic peptides or recombinant proteins are used to generate and validate antibodies .

  • Cross-Reactivity: Some antibodies (e.g., H4 acetyl-specific) exhibit iterative recognition of multi-acetylated peptides, highlighting the need for rigorous testing .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your orders. Delivery times may vary depending on the purchasing method or location. For specific delivery timeframes, please consult your local distributors.
Synonyms
Histone H4, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4, H4/A H4FA, H4/I H4FI, H4/G H4FG, H4/B H4FB, H4/J H4FJ, H4/C H4FC, H4/H H4FH, H4/M H4FM, H4/E H4FE, H4/D H4FD, H4/K H4FK, H4/N H4F2 H4FN HIST2H4, H4/O H4FO,
Target Names
HIST1H4A
Uniprot No.

Target Background

Function
Histone H4 is a core component of the nucleosome, which wraps and compacts DNA into chromatin. This process limits DNA accessibility to cellular machinery that requires DNA as a template. Consequently, histones play a crucial role in regulating transcription, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is regulated through a complex set of post-translational modifications of histones, often referred to as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Studies indicate that PP32 and SET/TAF-Ibeta proteins inhibit HAT1-mediated H4 acetylation. PMID: 28977641
  2. Research suggests that post-translational modifications of histones, including trimethylation of lysine 36 in H3 (H3K36me3) and acetylation of lysine 16 in H4 (H4K16ac), are involved in DNA damage repair. H3K36me3 stimulates H4K16ac following DNA double-strand breaks. SETD2, LEDGF, and KAT5 are essential for these epigenetic changes. (SETD2 = SET domain containing 2; LEDGF = lens epithelium-derived growth factor; KAT5 = lysine acetyltransferase 5) PMID: 28546430
  3. Data demonstrate that Omomyc protein co-localizes with proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5), and histone H4 H4R3me2s-enriched chromatin domains. PMID: 26563484
  4. H4K12ac is regulated by estrogen receptor-alpha and is linked to BRD4 function and inducible transcription. PMID: 25788266
  5. Systemic lupus erythematosus appears to be associated with an imbalance in histone acetyltransferases and histone deacetylase enzymes, favoring pathological H4 acetylation. PMID: 25611806
  6. Sumoylated human histone H4 prevents chromatin compaction by inhibiting long-range internucleosomal interactions. PMID: 25294883
  7. Acetylation at lysine 5 of histone H4 is associated with lytic gene promoters during the reactivation of Kaposi's sarcoma-associated herpesvirus. PMID: 25283865
  8. An increase in histone H4 acetylation caused by hypoxia in human neuroblastoma cell lines correlates with increased levels of N-myc transcription factor in these cells. PMID: 24481548
  9. Data indicate that histone assembly during the G1 phase is restricted to CENP-A and H4. PMID: 23363600
  10. This research focused on the distribution of a specific histone modification, namely H4K12ac, in human sperm and characterized its specific enrichment sites in promoters throughout the whole human genome. PMID: 22894908
  11. SRP68/72 heterodimers are major nuclear proteins whose binding of the histone H4 tail is inhibited by H4R3 methylation. PMID: 23048028
  12. TNF-alpha inhibition of AQP5 expression in human salivary gland acinar cells is attributed to an epigenetic mechanism involving the suppression of acetylation of histone H4. PMID: 21973049
  13. Our findings suggest that global histone H3 and H4 modification patterns are potential markers of tumor recurrence and disease-free survival in non-small cell lung cancer. PMID: 22360506
  14. HAT1 differentially impacts nucleosome assembly of H3.1-H4 and H3.3-H4. PMID: 22228774
  15. Phosphorylation of histone H4 Ser 47, catalyzed by the PAK2 kinase, promotes nucleosome assembly of H3.3-H4 and inhibits nucleosome assembly of H3.1-H4 by increasing the binding affinity of HIRA to H3.3-H4 and reducing the association of CAF-1 with H3.1-H4. PMID: 21724829
  16. The imatinib-induced hemoglobinization and erythroid differentiation in K562 cells are associated with global histone H4 acetylation. PMID: 20949922
  17. Our findings reveal the molecular mechanisms by which the DNA sequences within specific gene bodies are sufficient to nucleate the monomethylation of histone H4 lysine 200, which, in turn, reduces gene expression by half. PMID: 20512922
  18. Expression is downregulated by zinc and upregulated by docosahexaenoate in a neuroblastoma cell line. PMID: 19747413
  19. Low levels of histone acetylation are associated with the development and progression of gastric carcinomas, possibly through alteration of gene expression. PMID: 12385581
  20. Overexpression of MTA1 protein and acetylation levels of histone H4 protein are closely related. PMID: 15095300
  21. Peptidylarginine deiminase 4 regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. Data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones. PMID: 15345777
  22. The lack of biotinylation of K12 in histone H4 is an early signaling event in response to double-strand breaks. PMID: 16177192
  23. The incorporation of acetylated histone H4-K16 into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and impedes the ability of chromatin to form cross-fiber interactions. PMID: 16469925
  24. Apoptosis is associated with global DNA hypomethylation and histone deacetylation events in leukemia cells. PMID: 16531610
  25. BTG2 contributes to retinoic acid activity by favoring differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels. PMID: 16782888
  26. There is a relationship between histone H4 modification, epigenetic regulation of BDNF gene expression, and long-term memory for extinction of conditioned fear. PMID: 17522015
  27. The H4 tail and its acetylation play novel roles in mediating the recruitment of multiple regulatory factors that can alter chromatin states for transcription regulation. PMID: 17548343
  28. Brd2 bromodomain 2 is monomeric in solution and dynamically interacts with H4-AcK12. Additional secondary elements in the long ZA loop may be a common characteristic of BET bromodomains. PMID: 17848202
  29. Spermatids Hypac-H4 impairment in mixed atrophy did not deteriorate further by AZFc region deletion. PMID: 18001726
  30. The SET8 and PCNA interaction couples H4-K20 methylation with DNA replication. PMID: 18319261
  31. H4K20 monomethylation and PR-SET7 are crucial for L3MBTL1 function. PMID: 18408754
  32. High expression of acetylated H4 is more prevalent in aggressive than indolent cutaneous T-cell lymphoma. PMID: 18671804
  33. Our findings indicate a significant role of histone H4 modifications in bronchial carcinogenesis. PMID: 18974389
  34. Results suggest that acetylation of histone H4 K16 during S-phase, early replicating chromatin domains acquire the H4K16ac-K20me2 epigenetic label that persists on the chromatin throughout mitosis and is deacetylated in early G1-phase of the next cell cycle. PMID: 19348949
  35. Acetylated H4 is overexpressed in diffuse large B-cell lymphoma and peripheral T-cell lymphoma relative to normal lymphoid tissue. PMID: 19438744
  36. The release of histone H4 by holocrine secretion from the sebaceous gland may play a critical role in innate immunity. PMID: 19536143
  37. Histone modifications, including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4, may be involved in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation. PMID: 19578722
  38. A role of Cdk7 in regulating elongation is further suggested by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36—two marks of elongation—within genes when the kinase was inhibited. PMID: 19667075
  39. Data showed the dynamic fluctuation of histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors. PMID: 19805290
  40. Data directly implicate BBAP in the monoubiquitylation and additional posttranslational modification of histone H4 and an associated DNA damage response. PMID: 19818714

Show More

Hide All

Database Links

HGNC: 4781

OMIM: 142750

KEGG: hsa:121504

STRING: 9606.ENSP00000367034

UniGene: Hs.143080

Involvement In Disease
Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.
Protein Families
Histone H4 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is HIST1H4A K59 formylation and its biological significance?

Formylation at lysine 59 (K59) of histone H4 represents a post-translational modification (PTM) of the histone tail. This modification occurs on the core component of nucleosomes, which are fundamental in wrapping and compacting DNA into chromatin, thereby regulating DNA accessibility . HIST1H4A formylation is part of the complex "histone code" that contributes to chromatin structure regulation and gene expression control. Unlike more extensively studied modifications such as acetylation and methylation, formylation represents a less characterized but potentially significant regulatory mechanism in chromatin biology.

The biological significance of K59 formylation likely relates to specific nuclear processes including DNA replication, transcription regulation, and DNA damage response, though research on this specific modification is still evolving compared to other histone modifications .

How should researchers differentiate between Formyl-HIST1H4A (K59) Antibody and antibodies targeting other H4 modifications?

Researchers should implement rigorous specificity testing to differentiate between antibodies targeting various H4 modifications. As demonstrated in comprehensive analyses of histone antibodies, cross-reactivity between different modifications is common and must be carefully controlled . For example, antibodies targeting acetylated H4 lysines often show enhanced binding to peptides with multiple acetylation marks, with signal intensity increasing with acetylation content .

When using Formyl-HIST1H4A (K59) Antibody, researchers should:

  • Perform peptide competition assays using both target (formyl-K59) and non-target peptides (other H4 modifications)

  • Include appropriate controls in experiments, such as samples where formylation is enzymatically removed

  • Consider the potential impact of neighboring modifications on antibody binding

  • Validate findings using orthogonal techniques when possible

The Histone Antibody Specificity Database provides valuable information on antibody cross-reactivity that can guide experimental design and interpretation .

What are optimal sample preparation methods for detecting HIST1H4A K59 formylation?

For optimal detection of HIST1H4A K59 formylation, sample preparation should preserve the target modification while minimizing background. Based on established protocols for similar histone modifications, researchers should consider:

For immunocytochemistry applications:

  • Fix cells in 4% formaldehyde

  • Permeabilize using 0.2% Triton X-100

  • Block with 10% normal goat serum for 30 minutes at room temperature

  • Incubate with primary antibody (optimally diluted, typically 1:10-1:100) at 4°C overnight

For Western blot applications:

  • Treat samples with sodium butyrate (typically 10mM for 4-24 hours) to preserve histone modifications

  • Use PVDF membrane for protein transfer

  • Block thoroughly to prevent non-specific binding

  • Follow manufacturer's recommended antibody dilution (typically starting with 0.1 μg/mL)

These protocols may require optimization for specific experimental conditions and cell types.

How can researchers validate the specificity of Formyl-HIST1H4A (K59) Antibody?

Validating antibody specificity is critical for reliable results. For Formyl-HIST1H4A (K59) Antibody, a multi-faceted validation approach should include:

  • Peptide array analysis: Test antibody binding against a panel of modified and unmodified histone peptides to assess potential cross-reactivity with other modifications

  • Western blot validation: Compare reactivity in samples with and without treatments that affect formylation levels. Expected molecular weight for histone H4 is approximately 12 kDa

  • Knockout/knockdown controls: Where possible, utilize genetic models with altered histone modification machinery

  • Dot blot titration: Assess antibody specificity across a range of concentrations of modified and unmodified peptides

  • Specificity Factor calculation: As demonstrated in peptide array studies, calculate the ratio between binding to target site versus best non-target site :

Researchers should document validation results thoroughly and be transparent about any cross-reactivity observed.

What dilution ranges are recommended for Formyl-HIST1H4A (K59) Antibody in different applications?

Based on similar histone modification antibodies and manufacturer recommendations, the following dilution ranges provide starting points for optimization:

ApplicationRecommended Dilution RangeNotes
Immunocytochemistry (ICC)1:10-1:100Start with 1:10 for tissues with low expression
Western Blot1:500-1:2000Higher dilutions for high expression samples
ELISA1:1000-1:5000May require optimization based on sample type
ChIP1:50-1:200Protocol-dependent, titration recommended

It is essential to perform antibody titration experiments for each application and cell type. For example, in immunocytochemistry applications with HeLa cells, an initial dilution of 1:10 is recommended for Formyl-HIST1H4A (K59) Antibody .

How should interference from neighboring histone modifications be addressed?

Neighboring modifications can significantly impact antibody recognition of the target epitope through epitope masking or enhancement effects. Studies with histone H4 acetylation antibodies have shown that multiple modifications on the same histone tail can dramatically alter antibody binding properties .

To address potential interference:

  • Use peptide arrays: Test antibody binding against peptides containing the target modification (K59 formylation) in combination with various neighboring modifications

  • Sequential ChIP: Perform immunoprecipitation with antibodies against potentially interfering modifications, followed by Formyl-HIST1H4A (K59) Antibody

  • Mass spectrometry validation: Use LC-MS/MS to independently confirm the presence and stoichiometry of modifications

  • Combinatorial analysis: When analyzing genome-wide data, look for correlations between K59 formylation and other histone marks to identify potential interdependencies

The existence of epitope masking effects has been documented for histone H4, where additional acetylation marks can influence antibody recognition . Researchers should design control experiments that account for these potential interactions.

How can Formyl-HIST1H4A (K59) Antibody be optimized for ChIP-seq experiments?

ChIP-seq optimization for Formyl-HIST1H4A (K59) Antibody requires careful consideration of several factors:

  • Antibody amount optimization: Titrate antibody concentrations to determine the minimum amount needed for efficient immunoprecipitation while minimizing background

  • Crosslinking conditions: Standard 1% formaldehyde fixation for 10 minutes at room temperature is a starting point, but optimization may be necessary

  • Sonication parameters: Aim for chromatin fragments of 200-500 bp for optimal resolution

  • Input controls: Include input chromatin samples at multiple sequencing depths

  • Spike-in normalization: Consider using exogenous spike-in controls for quantitative comparisons between samples

  • Validation by qPCR: Before sequencing, validate enrichment at expected genomic locations versus control regions by qPCR

The gold standard for histone PTM antibodies is their utility in ChIP assays, and characterization by peptide microarray can inform on target recognition in ChIP . Researchers should verify that antibodies perform consistently across both platforms.

What strategies can resolve contradictory results between different detection methods?

When facing contradictory results between different detection methods (e.g., Western blot versus ChIP versus immunofluorescence), researchers should implement the following systematic approach:

  • Examine epitope accessibility: Different techniques expose epitopes differently; formylation at K59 may be differentially accessible depending on chromatin context and sample preparation

  • Consider fixation artifacts: Formaldehyde fixation can potentially create formyl adducts that might interfere specifically with formylation detection

  • Evaluate antibody batch variation: Compare lot numbers and request validation data from manufacturers

  • Implement orthogonal approaches: Combine antibody-based methods with mass spectrometry or other antibody-independent techniques

  • Statistical reanalysis: Apply appropriate statistical tests to determine if apparent contradictions are statistically significant

An analytical framework for resolving contradictions might include:

MethodSample PreparationEpitope ExposurePotential ArtifactsResolution Strategy
Western BlotDenatured proteinsCompletePotential cross-reactivityUse multiple antibodies
ChIPNative or cross-linked chromatinContext-dependentEpitope maskingValidate with spike-in controls
ICC/IFFixed cellsDepends on fixationAutofluorescenceInclude absorption controls
ELISAPurified proteinsHighMatrix effectsUse multiple antibody pairs

How does formylation at K59 interact with other histone H4 modifications in the epigenetic code?

Understanding the interplay between K59 formylation and other modifications requires sophisticated experimental approaches:

  • Co-occurrence analysis: ChIP-seq data can reveal genomic regions where formylation coincides with or excludes other modifications

  • Sequential ChIP: Performing sequential immunoprecipitations with antibodies against different modifications can identify co-occurrence at the same nucleosome

  • Mass spectrometry: Tandem mass spectrometry can identify peptides carrying multiple modifications simultaneously

  • Biochemical assays: In vitro assays testing how existing modifications affect the activity of enzymes that add or remove formylation

Studies of histone H4 acetylation have shown that site-specific antibodies often preferentially bind epitopes with iterative increases in acetylation content . Similar patterns may exist for formylation in relation to other modifications.

What linearity and dynamic range considerations apply to Formyl-HIST1H4A (K59) Antibody assays?

Establishing the linear detection range is crucial for quantitative applications of Formyl-HIST1H4A (K59) Antibody. Based on data from similar histone modification ELISA assays, researchers should consider:

  • Standard curve generation: Create standard curves using recombinant or synthetic peptides containing the formyl-K59 modification

  • Dilution linearity testing: Similar to what has been shown for HIST1H4A ELISA kits, samples should be tested at multiple dilutions (1:1, 1:2, 1:4, 1:8) to establish linearity

  • Recovery assessment: Spike known quantities of formylated peptides into samples to determine recovery percentages across the assay range

Typical performance parameters based on similar histone assays include:

ParameterExpected PerformanceValidation Method
Intra-assay PrecisionCV% < 8%Testing known samples 20× on one plate
Inter-assay PrecisionCV% < 10%Testing known samples across 20 different assays
Recovery85-115%Spiking known quantities into various matrices
LinearityWithin 20% of expected values across dilutionsSerial dilution testing

Researchers should establish these parameters for their specific experimental conditions.

How should researchers interpret ChIP-seq data generated using Formyl-HIST1H4A (K59) Antibody?

Interpreting ChIP-seq data requires careful analytical approaches:

  • Peak calling optimization: Different peak calling algorithms (MACS2, SICER, etc.) may perform differently for broad versus narrow histone modification patterns

  • Signal distribution analysis: Examine whether formyl-K59 signals are enriched at specific genomic features (promoters, enhancers, gene bodies)

  • Comparison with other modifications: Analyze co-occurrence with other histone marks to place formyl-K59 in the broader epigenetic context

  • Integration with gene expression: Correlate formyl-K59 enrichment with RNA-seq data to understand functional implications

  • Biological replicates analysis: Assess reproducibility between replicates using correlation and overlap metrics

Studies with other histone modifications have shown that antibody cross-reactivity can contribute to inaccurate mapping in genome-wide analyses . Researchers should be particularly cautious about potential cross-reactivity with other histone H4 modifications when interpreting genomic distribution data.

What are the most reliable normalization strategies for quantitative analysis of HIST1H4A K59 formylation?

Normalization is critical for accurate quantitative analysis of histone modifications. Based on established practices for histone PTM analysis, researchers should consider:

  • Internal normalization controls: Use unmodified histone H4 levels as a denominator for relative quantification

  • Spike-in standards: Add known quantities of isotopically labeled formylated peptides or recombinant modified histones

  • Reference gene normalization: For ChIP-qPCR, include invariant genomic regions as references

  • Total histone normalization: Express formyl-K59 levels relative to total H4 content

A hierarchical normalization strategy might include:

LevelNormalization ApproachApplicationConsiderations
Sample PreparationEqual cell numbersWestern, ELISACell size variations may affect results
TechnicalEqual total proteinWestern, ELISAMay mask global changes
Histone-specificRatio to unmodified H4All methodsMost direct comparison
Genome-wideSpike-in controlsChIP-seqAllows cross-sample comparison

When analyzing ChIP-seq data, researchers should be aware that cross-reactivity issues with other histone marks can affect peak calling and quantitative analyses .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.